A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

Remdesivir Approved as First COVID-19 Treatment

The U.S. Food and Drug Administration (FDA) has approved the antiviral drug remdesivir (brand name Veklury, Gilead Sciences) for treating patients hospitalized with COVID-19. This is the first treatment for COVID-19 to receive FDA approval.…

Top Dental Metrics to Maximize Practice Profitability

Dentists may have hidden profits in their practice that they’re not earning due to lack of information. There are many software tools that allow dental teams to collect metrics on key information. However, the trick comes in how it’s…

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy